Featured Article
The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Latest Features
The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
To examine the link between cardiovascular disease and sleep apnea, The Cardiology Advisor spoke with cardiologist Seth S. Martin, MD, MHS, FACC, FAHA and sleep specialist Rachel Marie E. Salas, MD, FAAN.
Managing Heart Failure: Improving Quality of Life and Preventing Excerbations
Heart failure is the number 1 reason for patient re-admittance to acute-care facilities according to the American Heart Association.
Preventing Heart Failure One Risk Factor at a Time
Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.
Hope for Heart Failure in Thyroid Hormone Therapy
Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.
Premature Ventricle Contractions in Heart Failure: A Closer Examination
A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.
ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD
While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.
Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"
Drs Tauras and Patel from Montefiore Medical Center in the Bronx, New York weigh in on what the new heart failure therapeutic guidelines mean for practicing clinicians.
Managing Cardiovascular Complications of Oncology Treatment
Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.
Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure
Ixmyelocel-T therapy reduced clinical cardiac events and improved patient outcomes.
Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD
Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.
Latest News
Annual Flu Shots Shown to Reduce CV Death Risk in Heart Failure
A study published in Circulation has found a reduced risk of cardiovascular (CV) death in heart failure patients when they are given routine influenza vaccinations.
Radiofrequency Renal Denervation Inhibits RAS in Heart Failure
Compared with the sham control, there were noticeable reductions in renal norepinephrine levels and circulating angiotensin I and II in swine that underwent radiofrequency renal denervation.
Predictors of Transcatheter Mitral Valve Repair Quality of Life Outcomes
Having atrial fibrillation, using home oxygen, having severe lung disease, or having a permanent pacemaker were predictive of lower health status after transcatheter mitral valve repair.
Quality-of-Life Outcomes With Natriuretic Peptide-Guided Therapy for Heart Failure
An N-terminal pro-B-type natriuretic peptide-guided treatment strategy is more costly and non-superior to usual care in heart failure.
Dapagliflozin Lowers Heart Failure Hospitalization Rates in High-Risk Patients With Diabetes
Dapagliflozin was not associated with either a higher or lower rate of MACE compared with placebo in patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease.
Sacubitril-Valsartan Superior to Enalapril for Reducing NT-proBNP in HFrEF
A sacubitril-valsartan therapy regimen was associated with greater reductions in NT-proBNP concentrations in patients with HFrEF compared with enalapril.
Use of Both Aspirin and NSAIDs Associated With Incident Heart Failure Risk
The use of both NSAID and aspirin was positively associated with incident HF in adults with no prior history of CVD.
IABP Devices Being Evaluated By the FDA Due to Battery Complications
There have been over 75 medical device reports of the cardiac assist Maquet/Datascope IABP devices shutting down while running on battery.
Data Support Efficacy of Heart Failure Hospital Readmissions Reduction Program
The US Hospital Readmissions Reduction Program (HRRP) has successfully reduced readmission rates for certain conditions.
Risk for Congestive Heart Failure During Pregnancy in Cancer Survivors
Investigators sought to determine the incidence of cardiac decompensation during pregnancy in cancer survivors.
The Cardiology Advisor Articles
- Should Guidelines Use Higher Risk Thresholds When Recommending Statins for Primary CVD Prevention?
- Ezetimibe Plus Statins Modestly Reduce Cardiovascular Disease Event Risk
- ACC, AHA Publish Appropriate Use Criteria Guidelines for Peripheral Artery Intervention
- FDA: E-Liquids Found to Contain Undeclared Sildenafil and Tadalafil
- Ultrasound-Based Visualization of Silent Atherosclerosis May Improve Medication Adherence
- ACC Releases Consensus Decision Pathway for CVD Risk Reduction in T2D and ASCVD
- Childhood Behavioral Interventions May Promote Adult Cardiovascular Health
- US Medical Schools Increase in Diversity After Implementation of Accreditation Standards
- Botox Injections Explored to Reduce Postop AF in Cardiac Surgery
- AHA Scientific Statement: Low Risk of Side Effects With Statins
- Do More Aggressive Periprocedural Antibiotic Regimens Reduce Risk of Device-Related Infections?
- Adherence and Intensity of Lipid-Lowering Therapy Influence CV Risk
- Challenges in Weighing Costs, Therapeutic Benefits of Expensive Pharmaceuticals
- Sustained Systolic Blood Pressure Reductions With Barbershop Intervention
- Stethoscopes in ICU Show High Levels of Bacterial Contamination